We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 61-80 of 10,000 results
  1. Prostate cancer polygenic risk score and prediction of lethal prostate cancer

    Polygenic risk scores (PRS) for prostate cancer incidence have been proposed to optimize prostate cancer screening. Prediction of lethal prostate...

    Robert J. Klein, Emily Vertosick, ... Hans Lilja in npj Precision Oncology
    Article Open access 08 April 2022
  2. Is multiparametric MRI always needed in biopsy-naïve patients with abnormal digital rectal examination? A single-institutional experience combining clinical and micro-ultrasonography-based factors to optimize prostate cancer detection

    Purpose

    To assess the diagnostic performance of microultrasound-targeted biopsy (microUSTBx) and systematic biopsy (SBx) in detecting clinically...

    Pier Paolo Avolio, Massimo Lazzeri, ... Giovanni Lughezzani in World Journal of Urology
    Article 06 January 2024
  3. Comparison of Ga-PSMA PET MRI with mpMRI in localization and regional staging of prostate cancer

    Purpose

    To compare diagnostic accuracy in localization and detection of extraprostatic extension (EPE), seminal vesicle invasion (SVI), lymph node...

    Hiranya Deka, Ginil Kumar Pooleri, ... Vishnu Prasad in World Journal of Urology
    Article 14 March 2024
  4. Intensive sampling of the umbra and penumbra improves clinically significant prostate cancer detection and reduces risk of grade group upgrading at radical prostatectomy

    Purpose

    Our objective is to evaluate the clinically significant prostate cancer detection rate of overlap** and perilesional systematic biopsy cores...

    Alvin Y. M. Lee, Kenneth Chen, ... Kae Jack Tay in World Journal of Urology
    Article 03 July 2023
  5. The yin and yang of chromosomal instability in prostate cancer

    Metastatic prostate cancer remains an incurable lethal disease. Studies indicate that prostate cancer accumulates genomic changes during disease...

    Marc Carceles-Cordon, Jacob J. Orme, ... Veronica Rodriguez-Bravo in Nature Reviews Urology
    Article 02 February 2024
  6. The lived experience of prostate cancer: 10-year survivor perspectives following contemporary treatment of localized prostate cancer

    Purpose

    Studies relying on standardized instruments to measure patient-centered harms and benefits of cancer treatment may fail to capture important...

    Bashir Al Hussein Al Awamlh, Christopher J. D. Wallis, ... Laura M. Beskow in Journal of Cancer Survivorship
    Article 12 May 2023
  7. Can contralateral lymph-node metastases be ruled out in prostate cancer patients with only unilaterally positive prostate biopsy?

    Purpose

    Our study evaluated the diagnostic benefits of bilateral pelvic lymphadenectomy in prostate cancer patients with unilaterally positive...

    Bianca Michalik, Svenja Engels, ... Alexander Winter in International Journal of Clinical Oncology
    Article Open access 07 September 2023
  8. Urine-derived exosomal PSMA is a promising diagnostic biomarker for the detection of prostate cancer on initial biopsy

    Purpose

    It is well-established that the lack of accurate diagnostic modalities for prostate cancer (PCa) leads to overdiagnosis and overtreatments....

    Cheng-Bang Wang, Shao-Hua Chen, ... Fu-Bo Wang in Clinical and Translational Oncology
    Article 20 October 2022
  9. A cost-benefit analysis of mass prostate cancer screening

    Background

    Prostate cancer (PCa) causes a substantial health and financial burden worldwide, underscoring the need for efficient mass screening...

    Hiro Farabi, Najmeh Moradi, ... Aziz Rezapour in Cost Effectiveness and Resource Allocation
    Article Open access 05 May 2024
  10. Management of bone metastasis in prostate cancer

    Progression of bone metastases is the primary cause of death in prostate cancer, and skeletal-related events (SREs), including pathologic fractures,...

    Article 10 May 2023
  11. Vaccines as treatments for prostate cancer

    Prostate cancer is a leading cause of death in men worldwide. For over 30 years, growing interest has focused on the development of vaccines as...

    Ichwaku Rastogi, Anusha Muralidhar, Douglas G. McNeel in Nature Reviews Urology
    Article 06 March 2023
  12. Association between patient ethnicity and prostate cancer diagnosis following a prostate-specific antigen test: a cohort study of 730,000 men in primary care in the UK

    Background

    Black men have higher prostate-specific antigen (PSA) levels and higher prostate cancer incidence and mortality than White men, while Asian...

    Liz Down, Melissa Barlow, ... Tanimola Martins in BMC Medicine
    Article Open access 01 March 2024
  13. Coarse label refinement for improving prostate cancer detection in ultrasound imaging

    Purpose:

    Ultrasound-guided biopsy plays a major role in prostate cancer (PCa) detection, yet is limited by a high rate of false negatives and low...

    Minh Nguyen Nhat To, Fahimeh Fooladgar, ... Purang Abolmaesumi in International Journal of Computer Assisted Radiology and Surgery
    Article 28 March 2022
  14. Clinically significant prostate cancer (csPCa) detection with various prostate sampling schemes based on different csPCa definitions

    Background

    Combining targeted biopsy (TB) with systematic biopsy (SB) is currently recommended as the first-line biopsy method by the European...

    Fei Wang, Tong Chen, ... Lijun Xu in BMC Urology
    Article Open access 23 December 2021
  15. Prostate cancer presentation and management in the Middle East

    Background

    Although prostate cancer is a prevalent malignancy worldwide, its clinical presentation and management in the Middle East are not...

    Mutlay Sayan, Astrid Langoe, ... Layth Mula-Hussain in BMC Urology
    Article Open access 09 February 2024
  16. Evidence-based Prostate Cancer Screening Interventions for Black Men: A Systematic Review

    Abstract

    Prostate cancer is the second leading cause of death for men in the U.S. and Black men are twice as likely to die from the disease. However,...

    Abigail Lopez, Jared T. Bailey, ... Dede K. Teteh-Brooks in Journal of Racial and Ethnic Health Disparities
    Article Open access 10 July 2024
  17. Digital PET for recurrent prostate cancer: how the technology help

    Digital PET is characterized by high sensitivity, spatial and temporal resolution, with growing applications of this technology both in clinical...

    Maria Ricci, Bruno Carabellese, ... Andrea Cimini in Clinical and Translational Imaging
    Article 17 February 2023
  18. The diagnostic accuracy of micro-ultrasound for prostate cancer diagnosis: a review

    Purpose

    Micro-UltraSound (microUS) is a new imaging modality capable of identifying and targeting suspicious areas, which might further increase the...

    Pier Paolo Avolio, Giovanni Lughezzani, ... Rafael Sanchez-Salas in World Journal of Urology
    Article 09 August 2023
  19. Identification of incidental brain tumors in prostate cancer patients via PSMA PET/CT

    Purpose

    Brain metastases are rare in patients with prostate cancer and portend poor outcome. Prostate-specific membrane antigen positron emission...

    Lily A. McLaughlin, Onur Yildirim, ... Nelson S. Moss in Journal of Neuro-Oncology
    Article 29 May 2023
  20. Gastrodin inhibits prostate cancer proliferation by targeting canonical Wnt/β-catenin signaling pathway

    Prostate cancer is an epithelial malignant tumor occurring in the prostate and is the most common malignant tumor in the male genitourinary system....

    Ye-Mao Liu, An-Ding Wu, ... Wei-Ming Mao in Medical Oncology
    Article 27 December 2023
Did you find what you were looking for? Share feedback.